Navigation Links
Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease
Date:6/20/2008

arterial hypertension.

Circulation 2005; 111: 3105-3111

5. D'Alonzo GE, Barst RJ, Ayres SM et al. Survival in patients with

primary pulmonary hypertension: Results from a national prospective

registry. Ann Intern Med 1991; 115: 343-349.

6. Barst RJ, McGoon M, Torbicki A et al. Diagnosis and differential

assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2004;

43(Suppl S): 40S-47S

Actelion Ltd

Actelion Ltd is a biopharmaceutical company with its corporate headquarters in Allschwil/Basel, Switzerland. Actelion's first drug Tracleer(R), an orally available dual endothelin receptor antagonist, has been approved as a therapy for pulmonary arterial hypertension. Actelion markets Tracleer(R) through its own subsidiaries in key markets worldwide, including the United States (based in South San Francisco), the European Union, Japan, Canada, Australia and Switzerland. Actelion, founded in late 1997, is a leading player in innovative science related to the endothelium -- the single layer of cells separating every blood vessel from the blood stream. Actelion's over 1700 employees focus on the discovery, development and marketing of innovative drugs for significant unmet medical needs. Actelion shares are traded on the SWX Swiss Exchange (ticker symbol: ATLN).


'/>"/>
SOURCE Actelion Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Victory Pharma, Inc. Reports MGX006 Enters Into Pivotal Development Program
2. European Enrollment Begins in Pivotal Phase 3 Trial of Novel Combination Medicine Developed by Cogentus Pharmaceuticals
3. Medivation Initiates Second Pivotal Phase 3 Trial of Dimebon(TM) in Patients With Alzheimers Disease
4. Nephros Completes Pivotal U.S. Clinical Trial for its Hemodiafiltration Products
5. Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytrens Contracture
6. Vion Pharmaceuticals Announces Presentation of Interim Data from Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting
7. NicOx Completes Patient Enrollment in Third Naproxcinod Pivotal Phase 3 Study
8. Impliant Restarts Pivotal Clinical Trial for Patented TOPS(TM) Spine System
9. Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW
10. Delcath Updates Phase III Patient Enrollment as Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited
11. Pivotal Study Shows Physician/Nurse Teams Using SEDASYS(TM) System Reduced Risk of Over Sedation With Propofol
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... Feb. 26, 2015 Columbia Laboratories, Inc. ... Company"), a specialty pharmaceutical company focused on the ... initiate a Phase II clinical trial for COL-1077, ... transvaginal pipelle-directed endometrial biopsy in the second quarter ... ("IND") submission feedback from the United States Food ...
(Date:2/26/2015)... BOULDER, Colo. , Feb. 26, 2015 /PRNewswire/ ... and installation Company specializing in commercial indoor cannabis ... its continued evolution from start-up to fast-paced manufacturing ... Tom Bollich , current Director and CEO, ... .  "I,m extremely proud of what the team ...
(Date:2/26/2015)... 26, 2015  Technological advancements have revolutionized ... inexpensive and compact yet powerful solutions. This ... potent devices, lending momentum to the development ... http://photos.prnewswire.com/prnh/20150225/177944LOGO New analysis ... finds that nanomanufacturing will gain traction in ...
Breaking Medicine Technology:Columbia Laboratories to Initiate a Phase II Clinical Trial for COL-1077, Lidocaine Bioadhesive 10% Gel, in the Second Quarter of 2015 2Columbia Laboratories to Initiate a Phase II Clinical Trial for COL-1077, Lidocaine Bioadhesive 10% Gel, in the Second Quarter of 2015 3Surna, Inc. Announces Senior Leadership Changes 2Surna, Inc. Announces Senior Leadership Changes 3Surna, Inc. Announces Senior Leadership Changes 4Revolutionary Nanomanufacturing Technology to Approach Commercialization by 2020 2Revolutionary Nanomanufacturing Technology to Approach Commercialization by 2020 3Revolutionary Nanomanufacturing Technology to Approach Commercialization by 2020 4
(Date:2/26/2015)... The Reproductive Science Center of New Jersey ... in Lawrenceville, NJ. , Dr. Ziegler and ... physicians, and NJ Top Docs, have been recognized for ... of infertility and reproductive medicine. This dedicated team of ... providing current, high quality medical treatments to their patients ...
(Date:2/26/2015)... The hip resurfacing procedure at Texas Orthopedics ... John Short to resume his active lifestyle, it has improved ... Mt. Kilimanjaro, the highest free-standing mountain in the world, in ... his late 20s, Short suffered from early onset degeneration. His ... were bone on bone. , Then about five years ...
(Date:2/26/2015)... Deerfield, IL (PRWEB) February 26, 2015 ... present during adolescence and young adulthood. In response ... age group, and in support of National Eating ... and Medicine (SAHM) presents new evidence-based recommendations for ... adolescents and young adults, including a new approach ...
(Date:2/26/2015)... February 26, 2015 “ KnowNote ” was ... features the latest and coolest mobile applications on the iOS, ... and host of NewsWatch, conducted the app review and shared ... staying in rhythm and in tune. , Learning a musical ... people. But what if people could take something they already ...
(Date:2/26/2015)... 26, 2015 The federal litigation ... to move forward in the U.S. District Court, ... According to court records, the proceeding issued its ... Re: Xarelto Products Liability Litigation, No. 2592) , ... standards and procedures pertaining to the litigation’s Common ...
Breaking Medicine News(10 mins):Health News:RSCNJ Is Celebrating the Reopening of Their Newly Renovated Office 2Health News:RSCNJ Is Celebrating the Reopening of Their Newly Renovated Office 3Health News:Hip Resurfacing at Texas Orthopedics Enables Patient to Climb Mt. Kilimanjaro 2Health News:Hip Resurfacing at Texas Orthopedics Enables Patient to Climb Mt. Kilimanjaro 3Health News:SAHM: Medical Providers Have Vital Lead Role in Diagnosing, Treating Restrictive Eating Disorders in Adolescents and Young Adults 2Health News:SAHM: Medical Providers Have Vital Lead Role in Diagnosing, Treating Restrictive Eating Disorders in Adolescents and Young Adults 3Health News:A Modern Way to Learn Music was Featured on NewsWatch Television on January 30, 2015 2Health News:Federal Xarelto Lawsuits Progress, As Bernstein Liebhard LLP Comments on Issuance of Most Recent Pretrial Order 2Health News:Federal Xarelto Lawsuits Progress, As Bernstein Liebhard LLP Comments on Issuance of Most Recent Pretrial Order 3
... Barcelona, Spain: New research showing that almost half of ... health-related problems at the same time is one of ... conference of the European Society for Radiotherapy and Oncology ... the effect of the demographic time bomb caused by ...
... Neuroscientist Patrik Verstreken, associated with VIB and KU Leuven, ... genetic defects that leads to Parkinson,s using vitamin K2. ... was done in collaboration with colleagues from Northern Illinois ... the website of the authorative journal Science ., ...
... By Steven Reinberg HealthDay Reporter , THURSDAY, ... of excess sun exposure, young adults in the United States ... officials said Thursday. Both activities increase the risk for ... including potentially fatal melanoma. "People need to realize that ...
... By Ellin Holohan HealthDay Reporter , ... fitness-related lifestyles in middle age could significantly reduce the ... new study of more than 20,000 people suggests. ... Heart Association meeting in Atlanta, found that fit middle-aged ...
... 10 (HealthDay News) -- Inducing labor after a woman has ... infant,s risk of death before, during or shortly after birth ... says. However, babies born after induced labor were also ... care unit, said researchers led by Sarah Stock of the ...
... Reporter , THURSDAY, May 10 (HealthDay News) -- Some ... may have an increased risk for serious blood clots, ... methods include skin patches, implants and vaginal rings. To ... switching to the pill, the researchers said. Deep ...
Cached Medicine News:Health News:Cancer in the elderly: Research fails to keep up with demographic change 2Health News:Cancer in the elderly: Research fails to keep up with demographic change 3Health News:Cancer in the elderly: Research fails to keep up with demographic change 4Health News:Vitamin K2: New hope for Parkinson's patients? 2Health News:Many Young Adults at Risk of Skin Cancer: CDC 2Health News:Many Young Adults at Risk of Skin Cancer: CDC 3Health News:Fitness in Middle Age Lowers Medical Costs Later: Study 2Health News:Fitness in Middle Age Lowers Medical Costs Later: Study 3Health News:Induced Labor Late in Pregnancy Has Pros, Cons 2Health News:Blood Clot Risk Linked to Some Non-Pill Contraceptives 2Health News:Blood Clot Risk Linked to Some Non-Pill Contraceptives 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: